 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| . |  |
. |
Phase 1 malaria vaccine trial to begin
Rockville, Md., April 23, 2009 A U.S. biotechnology company says it will conduct the first clinical trial involving humans of a malaria vaccine that contains the whole malaria parasite. Sanaria Inc. of Rockville, Md., said it is using a weakened form of the whole malaria parasite that's been harvested from irradiated mosquitoes. Other malaria vaccine candidates use only small portions of the parasite. Sanaria said its vaccine will be assessed in 104 healthy volunteers beginning next month. Myron Levine, director of the University of Maryland School of Medicine's Center for Vaccine Development said the Sanaria vaccine is based, in part, on findings from parallel studies conducted during the early 1970s by teams at the Center for Vaccine Development and the Naval Medical Research Center. Levine said those findings were never translated into a vaccine development effort because the task was considered to be impossible. Share This Article With Planet Earth
Related Links Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
Bird flu found in Tibet: state media
Beijing (AFP) April 19, 2009Chinese officials had confirmed the outbreak of a deadly strain of bird flu among poultry in the Tibetan capital Lhasa, state media reported Sunday, quoting the ministry of agriculture. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2007 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
del.icio.us
Digg
Reddit
YahooMyWeb
Google
Facebook